Medindia
Unlock the benefits of registration Register
Medindia » Health In Focus

Preterm Risk Prediction Tests Not Suitable as Routine Screens

by Dr. Meenakshy Varier on March 14, 2017 at 10:29 PM
Listen to this News

Highlights:

Two methods of screening that were thought to be effective in predicting the risk of preterm delivery in first-time pregnancies only identified a limited number of preterm births.


According to a large study by a National Institutes of Health (NIH) research network, these two methods, one for measuring the length of cervix and the other for the level of fetal fibronectin, do not appear suitable for widespread screening.

‘New methods should be deduced to identify impending preterm birth and other adverse pregnancy conditions.’

Probable Factors of Pre-term Births

Previous studies have indicated that the two signs of impending preterm birth could be:

Cervix is the lower part of the uterus that shortens and dilates during labor. A short cervix was defined in this study as less than 25 mm.

Fetal fibronectin is a glue-like protein that secures the amniotic sac to the inside of the uterus. Fetal fibronectin is considered to be high if the level is 50 ng/mL or greater.

The amniotic sac is the fluid-filled membrane that protects the growing fetus. It breaks down and can be detected in vaginal discharge toward the end of pregnancy.

The study focused on spontaneous preterm delivery from labor that occurs naturally, and initiated through a cesarean section or induced labor for medical reasons.

Pre-term Delivery

Regular contractions that begin in the uterus before 37 weeks of pregnancy resulting in the opening of the cervix is defined as preterm labor. Full-term pregnancy is carried up to 40 weeks. Preterm labor increases health risks for the baby.

Some risk factors for preterm labor are infections, carrying twins or multiple fetuses, short interval between two pregnancies, anemia, inadequate prenatal care, hypertension during pregnancy and excess amniotic fluid.

Study

Researchers included 9,410 pregnant women with a single fetus at eight research centers in the United States. The study was conducted as part of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b) and was published in the Journal of the American Medical Association, JAMA.

The women underwent ultrasound testing to measure cervical length at:

Fetal fibronectin tests were conducted at:

Results

The two common tests that were used in this study that screened women through their pregnancy only helped identify a small proportion of the women who would eventually deliver preterm.

In the test that measures cervical length at 16 to 22 weeks, shorter cervix was found in 35 of 439 women (8%) who delivered spontaneously before the 37th week of pregnancy.

When the test was conducted at 22 to 31 weeks, shorter cervix was found in 94 of 403 women (23.3%) who delivered prematurely.

For the fibronectin test at 16 to 22 weeks, fibronectin levels were higher in 30 of 410 women (7.3%) who delivered spontaneously before the 37th week.

On testing at 22 to 30 weeks, fibronectin levels were higher in 31 of 384 women (8.1%) who delivered prematurely .

On combining the results of the two tests, no significant difference in results was observed.

The researchers thus concluded that irrespective of whether the two tests were conducted separately or combined, the methods fail to recognize adequate number of preterm births that is needed to support routine screening of first-time pregnancies.

"These methods of assessing women in their first pregnancy do not identify most of those who will later go on to have a spontaneous preterm delivery," said the study's senior author, Uma Reddy, M.D., of the Pregnancy and Perinatology Branch at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development.

"There is a need to develop better screening tests that can be performed early in pregnancy." Reddy added.

References:

  1. Uma Reddy et al.Predictive accuracy of serial transvaginal cervical length by ultrasound and quantitative vaginal fetal fibronectin for spontaneous preterm birth among nulliparous women. Journal of the American Medical Association; (2017) Doi:10.1001/jama.2017.1373.
  2. Fetal fibronectin test - (http://www.mayoclinic.org/tests-procedures/fetal-fibronectin/home/ovc-20201225)
  3. Preterm labor - (http://www.mayoclinic.org/diseases-conditions/preterm-labor/basics/definition/con-20035359)


Source: Medindia

Cite this Article

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dr. Meenakshy Varier. (2017, March 14). Preterm Risk Prediction Tests Not Suitable as Routine Screens. Medindia. Retrieved on Nov 21, 2024 from https://www.medindia.net/news/healthinfocus/preterm-risk-prediction-tests-not-suitable-as-routine-screens-168587-1.htm.

  • MLA

    Dr. Meenakshy Varier. "Preterm Risk Prediction Tests Not Suitable as Routine Screens". Medindia. Nov 21, 2024. <https://www.medindia.net/news/healthinfocus/preterm-risk-prediction-tests-not-suitable-as-routine-screens-168587-1.htm>.

  • Chicago

    Dr. Meenakshy Varier. "Preterm Risk Prediction Tests Not Suitable as Routine Screens". Medindia. https://www.medindia.net/news/healthinfocus/preterm-risk-prediction-tests-not-suitable-as-routine-screens-168587-1.htm. (accessed Nov 21, 2024).

  • Harvard

    Dr. Meenakshy Varier. 2017. Preterm Risk Prediction Tests Not Suitable as Routine Screens. Medindia, viewed Nov 21, 2024, https://www.medindia.net/news/healthinfocus/preterm-risk-prediction-tests-not-suitable-as-routine-screens-168587-1.htm.

View Non AMP Site | Back to top ↑